Title: Etiological Profile of Proptosis – A Prospective Study
Authors: Dr Kavitha P Vasu, Dr Manoj Venugopal
DOI: https://dx.doi.org/10.18535/jmscr/v5i3.201
Abstract
Purpose: To analyze the etiological profile of proptosis and to evaluate the outcome following treatment.
Materials & Methods: All patients with proptosis, who attended the ophthalmology outpatient department at a tertiary care hospital during a period of one and half years were included in the study. Information regarding history and clinical presentations were recorded. Patients were examined clinically and necessary investigations were done to confirm the etiopathological diagnosis. Treatment modalities were decided depending upon the etiology. Follow up was done after 1 week, 3 week, 6 week, 3 months, 6 months subsequently following treatment. Final analysis was done at 6 months follow up. In a period of one and half years, 40 patients were evaluated.
Results: 42.5% had inflammatory diseases, 35% with thyroid associated ophthalmopathy, 12.5% were neoplasms, 5% were trauma, and 2.5% each were vascular and other category. 72.5% were treated medically and 7.5% treated surgically. On final analysis, 52.5% were fully recovered, 40% were partially recovered, and 7.5% were not recovered following treatment. 40% had improvement in vision while 2.5% had worsening following treatment due to development of complications.
Conclusion: Proptosis being a symptom can be due to various diseases affecting the orbit. It can be symptomatic or asymptomatic depending upon the etiology and associated clinical features. The final visual outcome is fairly good with early diagnosis and prompt treatment.
Keywords: Proptosis, visual acuity, exophthalmometry, visual outcome, recovery.
References
1. Duke Elder, System of Ophthalmology. vol 13. General consideration in Diseases of orbit: part 2. Lacrimal orbital and para orbital diseases. St.Louis, CV Mosby:1974;781.
2. American Academy of Ophthalmology. Basic and clinical science course section 4. Ophthalmic pathology and intraocular tumors:2012-2013;231-235.
3. Sharma P, Tiwari PK, Ghimire PG, Ghimire P. NJMS. 2013;02(01):35-7.
4. Yohai et al. Survival factors in ROCM: Major review. Surv. Opthalmology : 39, 3-22,1994.
5. Bergin DJ, Wright JE, Orb, Cellulitis, Br.J. Opthal; 1986; 70. 174-178.
6. Shields J A, Scartozzi et al: Ophthalmology 2004 May 11 (5); 997- 1008. The 2002 Montogomery Lecture Part I.
7. Dallow K L, Pratt S G ,Approach to orbital diseases. In Albert and Jakobice F A -Vol.3; 1881- 1890.
8. Duke Elder Vol XIII, System of Ophthalmology, The Ocular Adnexa Part 2 – Ch. 14, Pg.9.
9. Rootman J. Diseases of the orbit -A multidisciplinary approach. Pg. 121 -124,1988.
10. Duane’s Clinical Ophthal; Vol 2, Ch. 35 Pg 3, Ch. 39, Pg 24.